[ad_1]
Specifically against the disease caused by the Ebola virus Zaire, Bundibugyo (in western Uganda) and Sudan, the three known strains that cause fatal human diseases.
The researchers analyzed blood plasma from 17 people who had recovered from Ebola.
Antibodies isolated from two survivors were linked to an essential protein of the virus, called glycoprotein or GP, species of Ebola virus from Zaire, Bundibugyo and Sudan, and prevented the virus virus from entering the host cells.
The Ebola virus uses GP to attach to cell membranes and initiate infection and, thanks to these antibodies, contagion is prevented by stopping viral entry into the host cell. 19659002] "The researchers conclude that these largely neutralizing antibodies are promising candidates for their further development as therapeutic molecules against several species of the Ebola virus," said the NIH.
The last major Ebola outbreak has begun this spring in the Democratic Republic of Congo, where, according to the latest figures from the World Health Organization (WHO), among the 4 In April and 9 July, 53 cases were detected in this country, of which 38 have were confirmed and 15 were probable.
Of these 53 cases, 29 died and 24 were cured and survived the disease.
In the 2013-2016 epidemic, which caused havoc in In West Africa, there were 28,652 cases, of which 15,261 were laboratory confirmed and 11,325 deaths, according to figures from the Centers for Disease Control and Prevention (CDC).
EFE / MF [19659009] (function (d, s, id) {
var js, fjs = d.getElementsByTagName (s) [0];
if (d.getElementById (id)) returns;
js = d.createElement (s); js.id = id;
js.src = "http://connect.facebook.net/en_LA/all.js#xfbml=1&appId=155574704533127";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
[ad_2]
Source link
